Anti-dsDNA: choice of assay in relation to clinical value
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Antibodies to DNA are quite specific for systemic lupus erythematosus (SLE) and occur in the majority of SLE patients. Therefore, their detection is an important diagnostic aid to the clinician. Detection of anti-dsDNA may precede the diagnosis of SLE by more than a year. Fluctuations in the level of anti-dsDNA in an individual patient may give important information on the clinical status of the patient. Four of the most important methods developed for the measurement of anti-dsDNA antibodies will be discussed in this paper: the Farr assay, the PEG assay, the indirect immunofluorescence test on Crithidia luciliae and the ELISA. They will also be compared with one commercially available (Farr) assay, the Amersham anti-dsDNA kit. Each method, detects a part of the spectrum of anti-dsDNA antibodies produced by a patient. The Farr assay is the most specific for SLE; however, milder forms of the disease in which patients have only low avidity anti-dsDNA may easily be missed by this technique. Clinically, high avidity anti-dsDNA is related more frequently to the occurrence of nephritis, whereas low avidity anti-dsDNA antibodies are found more often in patients with central nervous system involvement. Traditionally, SLE is considered an immune-complex disease, in which inflammatory processes are initiated by local deposition of DNA/anti-dsDNA complexes. More recently, a major role was thought to be played by crossreactions of anti-dsDNA with tissue constituents. Our current view, ho…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a consequence, not all assays will generate similar values, even after standardization [80].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [80]
In the citing paper
“As the Farr assay includes ammonium sulphate precipitation at high salt concentrations, a condition that dissociates dsDNA-anti-dsDNA complexes of low avidity, 4 this assay detects only antibodies with high avidity. 5”
In the citing paper
“High avidity anti-dsDNA antibodies are more specific for SLE than those with low avidity 5”
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · cited 1×
“General comparison of the five anti-dsDNA assays using sera of patients with SLE defned according to the revised criteria of the American Rheumatism Association [ 33 ], leads to high levels of correlations between the various assays.”
MethodAntinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
Tan, E. M. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60641-0 · Cited by 1,514 · cited 1×
“SLE has been termed an autoimmune disease because many antibodies detected in the circulation of such patients are directed to autoantigens, in particular nucleic acids and proteins associated with nucleic acids [2, 3].”
BackgroundTer Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572 · cited 1×
“An illustration of such a pattern is given in Fig. 3. These observations have been confirmed recently by Ter Borg et al. [ 46 ].”
BackgroundAarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.
Lafer, E. M., Rauch, J., Andrzejewski, C., Mudd, D., Furie, B., Furie, B., Schwartz, R. S., & Stollar, B. D. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.4.897 · Cited by 536
ANTIBODIES TO POLYNUCLEOTIDES IN HUMAN SERA: ANTIGENIC SPECIFICITY AND RELATION TO DISEASE
Koffler, D., Carr, R., Agnello, V., Thoburn, R., & Kunkel, H. G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.1.294 · Cited by 510
Polyspecificity of Monoclonal Lupus Autoantibodies Produced by Human-Human Hybridomas
Shoenfeld, Y., Rauch, J., Massicotte, H., Datta, S. K., André-Schwartz, J., Stollar, B. D., & Schwartz, R. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302243080802 · Cited by 450 · cited 1×
“Monoclonal antibodies to DNA were often found to crossreact with structures such as phospholipids, proteoglycans or other polynegative molecules [5, 6, 8, 51, 52].”
BackgroundRivera, J. A. (1971) · Military Medicine · doi:10.1093/milmed/136.1.96a · Cited by 446
Winfield, J. B., Faiferman, I., & Koffler, D. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108626 · Cited by 405
Wold, R. T., Young, F. E., Tan, E. M., & Farr, R. S. (1968) · Science · doi:10.1126/science.161.3843.806 · Cited by 378 · cited 1×
“Farr assay. The Farr assay employs ammonium sulphate precipitation to separate DNA/anti-dsDNA complexes from free (radiolabeled) DNA [ 21 ].”
Method
Research works printed but not linked: 4
- Aarden LA, Smeenk R (1982) Immunochemical properties of antibodies to DNA and their influence on detection methods. In: Kalden JR, Feltkamp TEW (eds) Antibodies to nuclear antigens. Excerpta Medica, Amsterdam, pp 23?28
- Izui S, Lambert PH, Miescher PA (1977) Failure to detect circulating DNA/anti-DNA complexes by four radioimmunochemical methods in patients with SLE. Clin Exp Immunol 30:384?392
- Faaber P, Capel PJA, Rijke GPM, Vierwinden G, Putte LBA van de, Koene RAP (1984) Crossreactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol 55:502?510
- Faaber P, Rijke GPM, Smeenk RJT, Capel PJA, Putte LBA van de, Berden JHM (1985) Crossreactivity of anti-DNA antibodies: a new clue for the pathogenesis of SLE? In: Peeters H (ed) Protides of the biological fluids, 33rd edn. Pergamon, London, pp 405?408
Cited by
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Linnik, M. D., Hu, J. Z., Heilbrunn, K. R., Strand, V., Hurley, F. L., Joh, T., & LJP 394 Investigator Consortium (2005) · Arthritis & Rheumatism · doi:10.1002/art.20980 · Cited by 209
Cardiel, M. H., Tumlin, J. A., Furie, R. A., Wallace, D. J., Joh, T., & Linnik, M. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23673 · Cited by 147
Development of Anti‐dsDNA Autoantibodies Prior to Clinical Diagnosis of Systemic Lupus Erythematosus
Arbuckle, M. R., James, J. A., Kohlhase, K. F., Rubertone, M. V., Dennis, G. J., & Harley, J. B. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00959.x · Cited by 130
Haugbro, K., Nossent, J. C., Winkler, T., Figenschau, Y., & Rekvig, O. P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016303 · Cited by 113
Metadata
- Authors
- Smeenk, R. J. T., van den Brink, H. G., Brinkman, K., Termaat, R. M., Berden, J. H. M., & Swaak, A. J. G.
- Affiliations
- Radboud University Nijmegen (NL)
- ORCID
- Brinkman, K.
- Venue
- Rheumatology International
- Published
- 1991-09
- Volume
- 11
- Issue
- 3
- Pages
- 101-107
- ISSN
- 0172-8172 (ISSN-L)
- 1437-160X
- OpenAlex
- W2058665079
- Cited by
- 75
- References
- 60
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 2
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Rheumatology International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, systemic lupus erythematosus, Farr assay, indirect immunofluorescence, Crithidia luciliae, ELISA, lupus nephritis, central nervous system involvement, immune complexes, lupus diagnosis
- MeSH terms
- Antibodies, Antinuclear, DNA, Humans, Lupus Erythematosus, Systemic, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.